Predictive Oncology (NASDAQ:AGPU) Releases Earnings Results

Predictive Oncology (NASDAQ:AGPU) posted its earnings results on Tuesday. The company reported $122.75 EPS for the quarter, FiscalAI reports. The firm had revenue of $0.01 million for the quarter.

Predictive Oncology Trading Up 119.8%

NASDAQ AGPU opened at $3.56 on Thursday. The company has a fifty day moving average price of $2.16. Predictive Oncology has a one year low of $1.03 and a one year high of $32.10. The firm has a market cap of $12.08 million, a P/E ratio of -0.26 and a beta of 1.40.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings initiated coverage on Predictive Oncology in a report on Monday, January 26th. They set a “sell (e+)” rating for the company. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Predictive Oncology presently has an average rating of “Sell”.

Predictive Oncology Company Profile

Predictive Oncology (NASDAQ: AGPU) is a biotechnology company focused on oncology-related research and product development that combines laboratory science with data analytics. The company positions itself to support precision medicine by applying computational methods and laboratory testing to better understand tumor biology and to accelerate the identification and development of oncology therapeutics and diagnostics.

Its activities include laboratory-based testing and analytic services intended to inform drug discovery and development, biomarker identification, and patient stratification efforts.